Promoter shareholding increased significantly by 45.78% YoY, while sector averages show no change, indicating strong insider confidence.

Institutional investors also increased holdings by 8.71% YoY, contrasting sharply with sector average stagnation, reinforcing positive sentiment around the stock.

Public shareholding growth of 8.87% YoY further aligns with rising interest, suggesting broader retail confidence in Senores Pharmaceuticals amidst a stable sector.